| Class 2 Device Recall Siemens ADVIA Centaur Enhance Estradiol Test | |
Date Initiated by Firm | January 13, 2016 |
Create Date | March 24, 2016 |
Recall Status1 |
Terminated 3 on January 08, 2018 |
Recall Number | Z-1240-2016 |
Recall Event ID |
73052 |
Product Classification |
Radioimmunoassay, estradiol - Product Code CHP
|
Product | Siemens ADVIA Centaur Enhance Estradiol
Test Code eE2
Catalog Number: 10490889, 10491445, 10697757
Product Usage:
For in vitro diagnostic use in the quantitative determination of estradiol in human serum and plasma (heparinized and EDTA) using the ADVIA Centaur, ADVIA Centaur XP, ADVIA Centaur XPT and ADVIA Centaur CP systems. |
Code Information |
All lots |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc 333 Coney St East Walpole MA 02032-1516
|
For Additional Information Contact | Same 508-668-5000 |
Manufacturer Reason for Recall | The drug fulvestrant (Faslodex) may cause falsely elevated estradiol results. |
FDA Determined Cause 2 | Device Design |
Action | Siemens issued an Urgent Medical Device Correction (UMDC) to affected Siemens Healthcare Diagnostics customers in the United States on January 13, 2016 to be delivered to customers on January 14, 2016 via Federal Express. An Urgent Field Safety Notice (UFSN) was sent out for distribution to all customers outside the United States on January 13, 2016.
The letters identified affected product, problem and the actions to be taken. Customers may continue to use the estradiol assays to report patient results however, the assays should not be used for patients being treated with fulvestrant. Customers where instructed to complete and return the Correction Effectiveness Check attached. For questions contact your Siemens Customer Care Center or your local Siemens technical support representative. |
Quantity in Commerce | 33604 units |
Distribution | Worldwide Distribution US Nationwide , AR, AU, AU, BD, BO, BR, CA, CH, CL, CN, CO, DO, EC, EG, HK, ID, IE, IL, IN, JP, KR, LK, LY, MX, MY, NI, NP, NZ, PE, PH, PY, SA, SG, SV, TH, TW, UY, VE, VN, and ZA. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|